RO4607381

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for RO4607381, covering 2020-01-02 to 2020-01-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent. [Phase 2]